JPMorgan analyst Jeffrey Zekauskas downgraded Cabot Corp. (NYSE: CBT) from Neutral to Underweight with a price target of $105.00.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE